PM

Piyush Madhukar Asre

Active Director Additional Director DIN 11297871
DIN 11297871 First appointment Sep 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Piyush Madhukar Asre

Data last updated:

Piyush Madhukar Asre is an Additional Director at Medathena Life Sciences Private Limited (since 2025). The company operates in Paper.

DIN 11297871
Primary Designation Additional Director
Industry Paper
First Appointment 13 Sep 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director13 Sep 2025Active

Directorship timeline

Open interactive timeline →
Medathena Life Sciences Private Limited
Premium access

Shareholding and investment profile for Piyush Madhukar Asre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Piyush Madhukar Asre

Piyush Madhukar Asre currently holds 1 directorship: Medathena Life Sciences Private Limited (Additional Director, since 13 Sep 2025).

Piyush Madhukar Asre was first appointed on 13 Sep 2025 as Additional Director at Medathena Life Sciences Private Limited.

The current boards of Piyush Madhukar Asre's companies include Basweshwar Jagannath Mhetre (Medathena Life Sciences Private Limited), Makhdoom Husainsab Killedar (Medathena Life Sciences Private Limited), Rupjyoti Das (Medathena Life Sciences Private Limited), Venoor Shreyas Kumar (Medathena Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available